Danaher to Buy Diagnostics Company Cepheid for $4 Billion

September 6, 2016 11:20 AM

16 0

Danaher to Buy Diagnostics Company Cepheid for $4 Billion

Deal marks a 54% premium over Cepheid’s closing share price Friday

The deal marks a 54% premium over Cepheid’s closing share price Friday, valuing the company at about $4 billion, including debt.

Also read: Medical tech firm Becton Dickinson to buy C.R. Bard for $24B

Read more

To category page

Loading...